Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04556617
Title PLX2853 in Combination With Abiraterone Acetate and Prednisone and in Combination With Olaparib in Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Recruitment Terminated
Gender male
Phase Phase Ib/II
Variant Requirements No
Sponsors Plexxikon

prostate adenocarcinoma


Olaparib + PLX2853

Abiraterone + PLX2853 + Prednisone

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.